CClinicalTrials.gg
TerminatedNCT00748449COLO-TDMUpdated Mar 6, 2026

Colonography Versus Colonoscopy in High Risk Patient

An interventional study of Colonoscopy and CT-colonography in Colorectal Cancer, sponsored by Assistance Publique - Hôpitaux de Paris. Terminated at 1 site in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-03-06.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Diagnostic

Why this study was terminated
No more inclusions
Phase
Not applicable
Study type
Interventional
Enrollment
39
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

to evaluate the acceptability of CT-colonography compared to colonoscopy for the detection of advanced adenomas in subpopulations at high risk of colorectal.

Read the detailed description

Secondary objective: to evaluate the medical and economic impact of the implementation of CT- colonography in this setting.Methodology: prospective multicenter randomized controlled trial with direct patient benefitN° of patients to be included: 600 Study follow-up :1 consultation and 3 phone contacts (M1, M6 and M12)Evaluation criteria:Main endpoint: acceptability of the colorectal cancer screening (% of enrolled patients having actually undergone the exploration)Secondary endpoints: - cost/effectiveness ratio of the 2 diagnostic tests with calculation of the economic and medical costs. - number of advanced adenoma detected in each group- number of CRC cases detected in each group

02

Conditions studied

  • Colorectal Cancer

Keywords

  • Colorectal advanced adenoma
  • Colorectal cancer polypectomy (endoscopic)
  • Colectomy
  • Colonoscopy with anaesthesia
  • CT-colonography
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's enrollment of 39 is below the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Surveillance of patients with a personal history of advanced adenoma or CRC:

  • Informed consent obtained
  • Age ≥ 18 and ≤ 80 years old
  • History of advanced adenomatous polyps
  • Or history of non metastatic CRC with curative surgery and without other treatment more than 2 years before enrollment.
  • Previous medical examination

Screening of patients with a Family history of CRC at high risk:

  • Informed consent obtained
  • Age ≥ 18 and ≤ 80 years old
  • First degree family history of colorectal cancer diagnosed \<60yrs during the five previous years-Previous medical examination

Exclusion criteria

Exclusion Criteria:

Personal histories

  • Age \< 18 or >80 years old
  • history of non adenomatous polyps
  • history of Metastatic CRC
  • familial adenomatous polyposis, Peutz-Jeghers syndrome, hereditary non polyposis colorectal cancer (HNPCC), juvenile polyposis syndrome
  • Familial history of familial adenomatous polyposis
  • Personal history of subtotal colectomy (but not of hemicolectomy, to confer to inclusion criteria)
  • Colonoscopy with a polyps resection dated more than 5 years and less than 2 years prior to enrollment.
  • Enrollment in another protocol
  • no health insurance affiliation Family histories
  • Age \< 18 or >80 years old
  • Patients with one or several family histories of first degree colorectal cancer occured to unknown age or diagnosed after 60 years old.
  • Eligible patients having already undergone colonoscopy screening
  • no health insurance affiliation
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
39 participants (actual)

Study arms

  • Active comparator
    1

    CT Colonography

    Procedure: CT-colonography

  • Active comparator
    2

    Colonoscopy

    Procedure: Colonoscopy

Interventions

  • ProcedureColonoscopy

    1 Colonoscopy

    Also known as: Colonoscopy or CT-colonography

  • ProcedureCT-colonography

    1 CT-colonography; Procedure/Surgery/Radiation

06

What researchers measure

Primary outcomes

  1. Percentage of patients who refuse to undergo an examination

    Time frame: 36 months

07

Study locations

1 site
  • Cochin
    Paris, 75014, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00748449
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
URC-CIC Paris Descartes Necker Cochin
Responsible party
Sponsor
First posted
Sep 8, 2008
Start date
Jun 2008
Primary completion
Dec 2009
Completion
Dec 2010
Last update
Mar 6, 2026

Study contacts

Frederic PRAT, MD, PhD
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion